Jude Phillip, assistant professor in the Department of Biomedical Engineering, received an R35 MIRA award from the National Institutes of Health.

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

He studies how tumor-recognizing T cells — a type of immune cell — respond to these solid tumors, and how to improve those responses to help patients. One research focus is on CD4, or "helper" T cells ...

More information: Ganesan Ramamoorthi et al, Antitumor CD4+ T helper 1 cells target and control the outgrowth of disseminated cancer cells, Cancer Immunology Research (2025). DOI: 10.1158/2326 ...

Panel E shows the flow cytometric analysis of peripheral blood on day 162. Panel F shows the CAR+CD4−CD8− T-cell counts in peripheral blood (blue line) and bone marrow (purple stars ...

The same team of scientists also showed that KROS 101 increased the proliferation of helper and cytotoxic T cells (CD4+ and CD8+), while decreasing T reg cell growth in a melanoma model.